Literature DB >> 16597572

High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients.

Einat Peles1, Mary Jeanne Kreek, Scott Kellogg, Miriam Adelson.   

Abstract

AIM: To evaluate whether effective methadone treatment affects cocaine use.
METHODS: 421 consecutive patients admitted to a methadone maintenance clinic in Israel (1993-2002) were prospectively studied. Patients' urine samples were analyzed for cocaine during months 1 and 13.
RESULTS: On admission 55(13.1%) of 421 patients had urine positive for cocaine and 366 had negative. Of the 55 cocaine-positive patients, 45(81.8%) stayed in treatment at least one year, as did 267(73%) of cocaine-negative. After one year (n=312) 31 of 45 cocaine users stopped and 25 of 267 started. Methadone dose was highest in 31 patients who stopped cocaine (176.1+/-42.1 mg/ day), followed by 14 who did not stop (161.4+/-37.5 mg/day), and 25 who started during treatment (122.9+/-48.7 mg/day), or 242 who never used cocaine (119.5+/-48.4 mg/day) (ANOVA, F=15.6, p<0.0005).
CONCLUSIONS: High methadone dose may reduce cocaine use in patients addicted to both heroin and cocaine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16597572     DOI: 10.1300/J069v25n01_07

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  18 in total

Review 1.  Extreme marginalization: addiction and other mental health disorders, stigma, and imprisonment.

Authors:  Mary Jeanne Kreek
Journal:  Ann N Y Acad Sci       Date:  2011-08       Impact factor: 5.691

Review 2.  Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.

Authors:  Mary Jeanne Kreek; Orna Levran; Brian Reed; Stefan D Schlussman; Yan Zhou; Eduardo R Butelman
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

3.  Treatment-like steady-state methadone in rats interferes with incubation of cocaine sensitization and associated alterations in gene expression.

Authors:  Francesco Leri; Yan Zhou; Brendan Carmichael; Erin Cummins; Mary Jeanne Kreek
Journal:  Eur Neuropsychopharmacol       Date:  2011-07-13       Impact factor: 4.600

Review 4.  The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals.

Authors:  Helen Fox; Rajita Sinha
Journal:  Adv Pharmacol       Date:  2014

5.  Pharmacotherapy in the treatment of addiction: methadone.

Authors:  Mary Jeanne Kreek; Lisa Borg; Elizabeth Ducat; Brenda Ray
Journal:  J Addict Dis       Date:  2010-04

6.  Steady-state methadone blocks cocaine seeking and cocaine-induced gene expression alterations in the rat brain.

Authors:  Francesco Leri; Yan Zhou; Benjamin Goddard; AnneMarie Levy; Derek Jacklin; Mary Jeanne Kreek
Journal:  Eur Neuropsychopharmacol       Date:  2008-11-06       Impact factor: 4.600

7.  One-year and cumulative retention as predictors of success in methadone maintenance treatment: a comparison of two clinics in the United States and Israel.

Authors:  Einat Peles; Shirley Linzy; Mary Kreek; Miriam Adelson
Journal:  J Addict Dis       Date:  2008

8.  Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency.

Authors:  David H Epstein; John Schmittner; Annie Umbricht; Jennifer R Schroeder; Eric T Moolchan; Kenzie L Preston
Journal:  Drug Alcohol Depend       Date:  2008-12-19       Impact factor: 4.492

9.  Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts.

Authors:  David A Nielsen; Vadim Yuferov; Sara Hamon; Colin Jackson; Ann Ho; Jurg Ott; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2008-07-23       Impact factor: 7.853

Review 10.  Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.

Authors:  Yan Zhou; Dmitri Proudnikov; Vadim Yuferov; Mary Jeanne Kreek
Journal:  Brain Res       Date:  2009-11-12       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.